|
ATP5D expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.506590E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.998160E-01 |
| Normal-vs-Stage2 |
7.923400E-01 |
| Normal-vs-Stage3 |
9.127800E-02 |
| Normal-vs-Stage4 |
4.946200E-01 |
| Stage1-vs-Stage2 |
2.850600E-01 |
| Stage1-vs-Stage3 |
9.038000E-01 |
| Stage1-vs-Stage4 |
7.149000E-01 |
| Stage2-vs-Stage3 |
2.185000E-01 |
| Stage2-vs-Stage4 |
4.778400E-01 |
| Stage3-vs-Stage4 |
6.125000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.308000E-02 |
| Normal-vs-AfricanAmerican |
4.314000E-02 |
| Normal-vs-Asian |
2.492400E-02 |
| Caucasian-vs-AfricanAmerican |
2.864800E-03 |
| Caucasian-vs-Asian |
5.413400E-01 |
| AfricanAmerican-vs-Asian |
7.654200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.526800E-01 |
| Normal-vs-Female |
1.433760E-01 |
| Male-vs-Female |
8.908400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.933800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.182400E-02 |
| Normal-vs-Age(61-80Yrs) |
5.157200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.901600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.614400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.279200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.140800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.144600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.075400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.572200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.064000E-01 |
| Normal-vs-Grade 2 |
4.552600E-01 |
| Normal-vs-Grade 3 |
1.046200E-01 |
| Normal-vs-Grade 4 |
2.172600E-01 |
| Grade 1-vs-Grade 2 |
6.141200E-01 |
| Grade 1-vs-Grade 3 |
7.571200E-01 |
| Grade 1-vs-Grade 4 |
9.220000E-01 |
| Grade 2-vs-Grade 3 |
7.445400E-01 |
| Grade 2-vs-Grade 4 |
6.394600E-01 |
| Grade 3-vs-Grade 4 |
7.820200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.181800E-04 |
| Normal-vs-ccB subtype |
2.122800E-03 |
| ccA subtype-vs-ccB subtype |
8.689800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.968600E-01 |
| Normal-vs-N1 |
2.503200E-01 |
| N0-vs-N1 |
5.330000E-01 |
|
|
